Inventor · disambiguated record
Helene Decornez
Also filed as: DECORNEZ HELENE · DECORNEZ HELENE Y · DECORNEZ HELENE YVONNE · DECORNEZ HÉLÈNE
7 granted patents·4 pending applications·44 citations·filing 2003–2016
82Inventor score
Top patents by PatentIndex Score
11 records- 0191US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 0287US9120749B2Quinoline derivatives and MELK inhibitors containing the sameMATSUO YO·Filed 2011·Granted Sep 1, 2015·14 cites·17 claims
- 0382US7790709B2Heterocyclic compounds, methods of making them and their use in therapyAFFINIUM PHARM INC·Filed 2003·Granted Sep 7, 2010·12 cites·14 claims
- 0480US8450307B2Therapeutic agents, and methods of making and using the sameSARGENT BRUCE J·Filed 2005·Granted May 28, 2013·9 cites·22 claims
- 0568US8962648B2Tricyclic compounds and PBK inhibitors containing the sameNAKAMURA YUSUKE·Filed 2011·Granted Feb 24, 2015·1 cites·14 claims
- 0658US9453025B2Tricyclic compounds and PBK inhibitors containing the sameONCOTHERAPY SCIENCE INC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 0749US2008269249A2Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditionsALCON INC·Filed 2005·Application pending·0 cites
- 0849US2011124633A1Heterocyclic Compounds, Methods of Making Them and Their Use in TherapyBERMAN JUDD·Filed 2010·Application pending·0 cites
- 0948US2014107106A1Therapeutic agents, and methods of making and using the sameAFFINIUM PHARM INC·Filed 2013·Application pending·0 cites
- 1042US2010216777A1Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditionsALCON INC·Filed 2010·Application pending·0 cites
- 1128US10508109B2Bicyclic compound and use thereof for inhibiting SUV39H2ONCOTHERAPY SCIENCE INC·Filed 2016·Granted Dec 17, 2019·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Helene Decornez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →